Does enteral immunonutrition reduce infection risks after gastric cancer surgery?
Enteral immunonutrition (EIN) is a specialized liquid formula that contains immune-boosting nutrients like arginine, glutamine, and omega-3 fatty acids. For people undergoing gastric cancer surgery, infections are a common and serious complication. Multiple studies show that using EIN around the time of surgery can significantly lower the chance of developing infections compared to standard nutrition formulas. The strongest evidence supports giving EIN for 7 to 10 days, starting before surgery and continuing afterward.
What the research says
A 2024 meta-analysis of 19 randomized controlled trials involving 1,653 patients found that EIN reduced the odds of infectious complications by 52% compared to standard enteral nutrition (OR = 0.48) 1. It also shortened hospital stays by about 1.24 days and improved immune markers like IgG, IgM, and IgA 1. An earlier meta-analysis of 7 studies (583 patients) confirmed that EIN given for at least 7 days after surgery increased CD4+ T cells, CD4/CD8 ratio, and immunoglobulin levels 8. A 2021 systematic review of 16 trials in gastrointestinal cancer patients also found that perioperative immunonutrition significantly lowered surgical site infection risk and shortened hospital stay 10. However, one 2012 trial in well-nourished patients found no benefit from preoperative-only EIN for 5 days before total gastrectomy 9. This suggests that timing matters: perioperative (before and after surgery) and longer duration (7–10 days) appear most effective, while preoperative-only use may not be enough 19.
What to ask your doctor
- Would enteral immunonutrition be appropriate for my surgery plan, and when should it start?
- What specific immune nutrients (arginine, glutamine, omega-3s) are in the formula you would recommend?
- How long would I need to take the immunonutrition before and after surgery?
- Are there any side effects or reasons I might not be a good candidate for this approach?
- Can you help me understand the expected reduction in infection risk based on my individual health status?
This question is drawn from common patient questions about Oncology and answered using cited medical research. We do not provide individualized advice.